Cargando…

Gastrointestinal Bleeding Rates Among Managed Care Patients Newly Started on COX-2 Inhibitors or Nonselective NSAIDs

OBJECTIVES: While cyclooxygenase-2 (COX-2) inhibitors were introduced to the U.S. market with the promise of less gastrointestinal (GI) toxicity than nonselective nonsteroidal anti-inflammatory drugs (NSAIDs), additional research is needed to examine this outcome in the naturalistic setting. The obj...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stockl, Karen, Cyprien, Lori, Chang, Eunice Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2005
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438022/ https://www.ncbi.nlm.nih.gov/pubmed/16137212 http://dx.doi.org/10.18553/jmcp.2005.11.7.550

Ejemplares similares

Balancing the gastrointestinal benefits and risks of nonselective NSAIDs
por: Peura, David A, et al.
Publicado: (2005)

Selective COX-2 inhibitor continues to be a safe alternative in patients with nonselective NSAIDs hypersensitivity
por: Thalappil, Sherin, et al.
Publicado: (2022)

Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance
por: Borer, Jeffrey S, et al.
Publicado: (2005)

Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
por: Harris, Randall E, et al.
Publicado: (2012)

Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors
por: Rostom, Alaa, et al.
Publicado: (2009)

Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs
por: Scheiman, James M, et al.
Publicado: (2005)

Relative Value of the NSAIDs, Including COX-2 Inhibitors and Meloxicam
por: Curtiss, Frederic R.
Publicado: (2006)

Cost-Effectiveness Evaluation of Etoricoxib versus Celecoxib and Nonselective NSAIDs in the Treatment of Ankylosing Spondylitis in Norway
por: Jansen, Jeroen P., et al.
Publicado: (2011)

Similar reductions in the risk of human colon cancer by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
por: Harris, Randall E, et al.
Publicado: (2008)

Comparative Risk of Cardiovascular Outcomes Between Topical and Oral Nonselective NSAIDs in Taiwanese Patients With Rheumatoid Arthritis
por: Lin, Tzu‐Chieh, et al.
Publicado: (2017)

Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use
por: Straube, Sebastian, et al.
Publicado: (2009)

Review of gastrointestinal bleeding during use of SSRIs combined with use of NSAID
por: Arts, M., et al.
Publicado: (2022)

Selective COX-2 inhibitors, NSAIDs and cardiovascular events – is celecoxib the safest choice?
por: Howes, Laurence Guy
Publicado: (2007)

Network Meta-Analysis Comparing Relatively Selective COX-2 Inhibitors Versus Coxibs for the Prevention of NSAID-Induced Gastrointestinal Injury
por: Yang, Man, et al.
Publicado: (2015)

Risk of gastrointestinal bleeding and cardiovascular events due to NSAIDs in the diabetic elderly population
por: Kim, Jungmee, et al.
Publicado: (2015)

Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case–control study
por: Moride, Yola, et al.
Publicado: (2005)

Do NSAIDs and ASA Cause More Upper Gastrointestinal Bleeding in Elderly than Adults?
por: Kocoglu, Hakan, et al.
Publicado: (2016)

Gastrointestinal toxicity among patients taking selective COX‐2 inhibitors or conventional NSAIDs, alone or combined with proton pump inhibitors: a case–control study
por: Bakhriansyah, Mohammad, et al.
Publicado: (2017)

New NSAID Conjugates as Potent and Selective COX-2 Inhibitors: Synthesis, Molecular Modeling and Biological Investigation
por: Bokhtia, Riham M., et al.
Publicado: (2023)

Adverse Effects of Oral Nonselective and cyclooxygenase-2-Selective NSAIDs on Hospitalization for Acute Kidney Injury: A Nested Case–Control Cohort Study
por: Chou, Chia-I., et al.
Publicado: (2016)

COX2 genetic variation, NSAIDs, and advanced prostate cancer risk
por: Cheng, I, et al.
Publicado: (2007)

Selective serotonin reuptake inhibitors increase risk of upper gastrointestinal bleeding when used with NSAIDs: a systemic review and meta-analysis
por: Alam, Syed Mobashshir, et al.
Publicado: (2022)

A cohort study to evaluate cardiovascular risk of selective and nonselective cyclooxygenase inhibitors (COX-Is) in arthritic patients attending orthopedic department of a tertiary care hospital
por: Bhosale, Uma A., et al.
Publicado: (2014)

Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis
por: Latimer, Nicholas, et al.
Publicado: (2009)

Nonselective Mevalonate Kinase Inhibitor as a Novel Class of Antibacterial Agents
por: Gharehbeglou, Mohammad, et al.
Publicado: (2015)

An observational study of the discrediting of COX-2 NSAIDs in Australia: Vioxx or class effect?
por: Parkinson, Lynne, et al.
Publicado: (2011)

COX-2: Where are we in 2003? - Distinction from NSAIDs becoming blurred
por: Day, Richard
Publicado: (2003)

Prescription Pattern of NSAIDs and the Prevalence of NSAID-induced Gastrointestinal Risk Factors of Orthopaedic Patients in Clinical Practice in Korea
por: Lee, Sung-Hun, et al.
Publicado: (2011)

Management of NSAID Associated Upper Gastrointestinal Problems
por: Cryer, Byron
Publicado: (2005)

Treatment and chemoprevention of NSAID-associated gastrointestinal complications
por: Frech, Edward J, et al.
Publicado: (2009)

Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity
por: McEvoy, L., et al.
Publicado: (2021)

How soon to start: aspirin resumption after upper gastrointestinal bleed?
por: Gooch, Rebecca, et al.
Publicado: (2010)

Carvedilol Versus Other Nonselective Beta Blockers for Variceal Bleeding Prophylaxis and Death: A Network Meta-analysis
por: Cheung, Ka-Shing, et al.
Publicado: (2023)

NSAID-Induced Enteropathy in Rheumatoid Arthritis Patients with Chronic Occult Gastrointestinal Bleeding: A Prospective Capsule Endoscopy Study
por: Tachecí, Ilja, et al.
Publicado: (2013)

Acute Middle Gastrointestinal Bleeding Risk Associated with NSAIDs, Antithrombotic Drugs, and PPIs: A Multicenter Case-Control Study
por: Nagata, Naoyoshi, et al.
Publicado: (2016)

The importance of provocation tests with COX2 inhibitors on patients with a history of cross-hypersensitivity to non-steroidal anti-inflammatory (NSAIDs)
por: Gonçalves, Tania Tavares
Publicado: (2015)

Concomitant Use of NSAIDs or SSRIs with NOACs Requires Monitoring for Bleeding
por: Lee, Min-Taek, et al.
Publicado: (2020)

Autophagy: More Than a Nonselective Pathway
por: Reggiori, Fulvio, et al.
Publicado: (2012)

The Effect of Diet Mixing on a Nonselective Herbivore
por: Groendahl, Sophie, et al.
Publicado: (2016)

CYP2C9 variants as a risk modifier of NSAID-related gastrointestinal bleeding: a case–control study
por: Figueiras, Adolfo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_knd4liv7cpapfdcsv5hg8l5spi